UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$498M |
| 2 |
Ametek
AME
|
+$445M |
| 3 |
Microsoft
MSFT
|
+$432M |
| 4 |
Apple
AAPL
|
+$209M |
| 5 |
Tesla
TSLA
|
+$198M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$759M |
| 2 |
Accenture
ACN
|
+$529M |
| 3 |
ConocoPhillips
COP
|
+$392M |
| 4 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$324M |
| 5 |
iShares Core S&P Small-Cap ETF
IJR
|
+$310M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.01% |
| 2 | Healthcare | 15.34% |
| 3 | Financials | 12.73% |
| 4 | Consumer Discretionary | 9.85% |
| 5 | Industrials | 8.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1926
Regenxbio
RGNX
$695M
| $782K | ﹤0.01% |
34,498
-1,997
| -5% | -$45.1K |
|
|
BBBY
1927
Bed Bath & Beyond
BBBY
$445M
| $780K | ﹤0.01% |
44,309
+7,264
| +20% | +$156K |
|
|
LPRO
1928
DELISTED
Open Lending Corp
LPRO
| $779K | ﹤0.01% |
115,368
+7,850
| +7% | +$55.2K |
|
|
BRY
1929
DELISTED
Berry Corp
BRY
| $777K | ﹤0.01% |
97,161
| – | – |
|
1930
Immunovant
IMVT
$8.19B
| $777K | ﹤0.01% |
43,754
+6,409
| +17% | +$80.7K |
|
1931
8x8 Inc
EGHT
$325M
| $775K | ﹤0.01% |
180,285
| – | – |
|
1932
Usana Health Sciences
USNA
$273M
| $774K | ﹤0.01% |
14,544
| – | – |
|
1933
Simulations Plus
SLP
$371M
| $767K | ﹤0.01% |
20,975
+1,842
| +10% | +$77.6K |
|
|
EFC
1934
Ellington Financial
EFC
$1.68B
| $766K | ﹤0.01% |
61,919
+7,505
| +14% | +$97.9K |
|
1935
Hackett Group
HCKT
$286M
| $765K | ﹤0.01% |
37,560
+7,627
| +25% | +$161K |
|
|
PTRA
1936
DELISTED
Proterra Inc. Common Stock
PTRA
| $764K | ﹤0.01% |
202,556
+39,294
| +24% | +$208K |
|
|
CDMO
1937
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $763K | ﹤0.01% |
55,446
| – | – |
|
1938
Coeur Mining
CDE
$17.6B
| $763K | ﹤0.01% |
227,036
| – | – |
|
1939
Monarch Casino & Resort
MCRI
$2.18B
| $762K | ﹤0.01% |
9,905
| – | – |
|
1940
Unitil
UTL
$968M
| $761K | ﹤0.01% |
14,812
+441
| +3% | +$22.4K |
|
1941
Compass
COMP
$9.62B
| $756K | ﹤0.01% |
324,330
+35,573
| +12% | +$93.3K |
|
|
RUTH
1942
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
| $755K | ﹤0.01% |
48,767
-5,128
| -10% | -$90.1K |
|
|
RWT
1943
Redwood Trust
RWT
$578M
| $751K | ﹤0.01% |
111,117
-18,205
| -14% | -$127K |
|
1944
Cerus
CERS
$478M
| $750K | ﹤0.01% |
205,555
+25,023
| +14% | +$94.3K |
|
|
EGLE
1945
DELISTED
Eagle Bulk Shipping Inc.
EGLE
| $750K | ﹤0.01% |
+15,020
| New | +$753K |
|
1946
Myers Industries
MYE
$1.29B
| $748K | ﹤0.01% |
33,655
+258
| +0.8% | +$5.36K |
|
1947
Mativ Holdings
MATV
$731M
| $747K | ﹤0.01% |
35,763
+13,312
| +59% | +$289K |
|
1948
ImmunityBio
IBRX
$7.98B
| $746K | ﹤0.01% |
147,198
+11,843
| +9% | +$65K |
|
1949
Janus International
JBI
$737M
| $744K | ﹤0.01% |
78,184
| – | – |
|
|
MCHB
1950
Mechanics Bancorp
MCHB
$3.69B
| $744K | ﹤0.01% |
26,965
+438
| +2% | +$12K |
|
Similar funds
UBS AM's Q4 2022 Portfolio in Review
As of Q4 2022, UBS AM held 2,824 positions worth $191B, up 7% from $178B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
UBS AM's Q4 2022 filing shows 88 new, 1,334 increased, 722 reduced and 301 closed positions. Its largest new stake was Ferguson: 543,379 shares worth $69M. The largest sale was Amgen, an estimated $759M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.
- UBS AM's largest Q4 2022 buy was Ferguson: 543,379 shares worth $69M.
- UBS AM added most to Amazon in Q4 2022, an estimated $498M increase.
- UBS AM's biggest Q4 2022 reduction was Accenture, cutting an estimated $529M.
- UBS AM fully exited Amgen in Q4 2022, selling an estimated $759M.
- UBS AM's ten largest holdings make up 19% of its $191B portfolio in Q4 2022.
- UBS AM opened 88 new positions and closed 301 in Q4 2022.
- UBS AM's portfolio value rose 7% quarter-over-quarter to $191B.
Based on UBS AM's 13F filing for Q4 2022, filed 14 Feb 2023.